Resiquimod 848 (VAdv-Ly0038)
| CAT | Size | Price | Quantity | |
|---|---|---|---|---|
| VAdv-Ly0038 |
|
Resiquimod 848, a guanosine derivative, TLR7/8 agonist vaccine adjuvant.
Datasheet
Specifications
Type
PRRs Agonist
Formula
C17H22N4O2▪HCl
Molecular Weight
350.8
Specificity
TLR7/8 agonist
Product Form
White solid
Endotoxin
Lower than 1 EU/mg.
Storage
Store at -20°C.
Shelf Life
1 year.
Adjuvant Information
Introduction
Resiquimod 848 is a low-molecular-weight imidazoquinoline compound that functions as an immune response modifier, exhibiting strong antiviral and antitumor effects. Its immunomodulatory properties stem from its capacity to stimulate the production of pro-inflammatory cytokines by activating Toll-like receptors 7 and 8 (TLR7 and TLR8).
Related Product
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
